期刊文献+

418例TCT联合阴道镜活检宫颈癌前病变的诊断分析 被引量:1

Effect 418 examples TCT union vaginoscope biopsy cervical cancer pathological change diagnostic analysis
原文传递
导出
摘要 目的:对TCT和阴道镜活检病理结果进行对比分析,并进一步探讨二者在宫颈癌前病变诊断中的价值. 方法:回顾性分析209例阳性宫颈的液基细胞学和对应的阴道镜活检病理检查的结果,进行对比研究.结果:209例阳性TCT病例中,ASCUS 194例(46.41%)、LSIL 112例(26.79%)、HSIL 104例(24.88%)、鳞状细胞癌8例(1.92%).416例经阴道镜下多点活检,病理诊断如下:炎症94例(22.49%)、CIN Ⅰ级140例(33.49% )、CIN Ⅱ级64例(15.31% )、CIN Ⅲ级102例(24.40% )、浸润癌18例(4.31%).与病理结果比较,209例TCT报告中,LSIL的诊断符合率58.93%(66/112),HSIL及以上病变的诊断符合率92.86%(104/112),LSIL与HSIL及以上搞变的诊断符合率比较,差异有显著性(X2=7.49,P〈0.01).结论:TCT作为宫颈病变的初筛手段,能够发现大量的宫颈癌前病变患者,结合阴道镜下活组织检查,大大提高了宫颈癌前病变的检出率. Objective: Carries on the contrast analysis to TCT and the vaginoscope biopsy pathology result,and further discusses the two the pathological change to diagnose in front of cervical cancer the value. Methods: The review analysis 209 example masculine cervix of the uterus fluid basal cell study and the corresponding vaginoscope biopsy pathology inspection result, conduct the contrast research. Results:In 209 example masculine TCT case of illness, ASCUS 194 examples (46.41%), LSIL 112 examples (26.79%), HSIL 104 examples (24. 88 %), squamose cell cancer 8 examples (1.92% ). 416 examples after the vaginoscope under the multi-spot biopsy, the pathological diagnosis are as follows: Inflammation 94 examples (22.49%) ,CIN ⅠLevel 140 examples (33.49 %) ,CIN ⅡLevel 64 examples (15.31%) ,CIN Ⅲ Level 102 examples (24. 40 %),infiltration cancer 18 examples (4.31%). Compares with the pathology result,in 209 example TCT report, LSIL diagnosis coincidence rate 58.93 % (66/112), HSIL and above pathological change diagnosis coincidence rate 92.86 % (104/112), LSIL and HSIL and above do the diagnosis coincidence rate which changes to compare, the difference has the significance (Х^2 = 7.49, P〈0. 01). Conclusion: TCT initially sieves the method as the cervix of the uterus pathological change, can discover in front of the massive cervical cancers the pathological change patient, unifies under the vaginoseope the living tissue inspection, enhanced in front of cervical cancer the patho- logical change to pick out greatly rate.
作者 郑小彬
出处 《按摩与康复医学》 2010年第20期27-28,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 TCT 宫颈癌前病变 阴道镜活检 TCT In front of cervical cancer pathological change Vaginoscope biopsy
  • 相关文献

参考文献3

二级参考文献19

  • 1New Pap Smear Technologies Promise Improved Sensitivity. 2000 by RR Inc. Http://www. cancemetwork. com /journals/ oncnews /n 9906v. htm.
  • 2Savage EW, Chapman G. Cervical dysplasia and cancer. In: Hacker NF, Moore JG. Essentials of Obstetrics and Gynecology. 3rd ed.Philadelphia: Saunders, 1998. 645.
  • 3Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus Guidelines for the management of woman with cervical cytological abnormalities. JAMA,2002,287 ( 16 ) :2120.
  • 4Lipscomb G H. Abnormal Pap Smear. In : Ling FW, Duff P (eds) Obstetrics and Gynecology, Principles for Practice. Beijing: McGraw-Hil1,2001. 1096.
  • 5连利娟.林巧稚妇科肿瘤学[M]:第3版[M].北京:人民卫生出版社,2001.139.
  • 6Klinkhamer PJ,Meerding WJ,Rosier PF,et al.Liquid-based cervical cytology[J].Cancer,2003,99 (5):263-271.
  • 7Nuovo J,Melnikow J,Howell LP.New tests for cervical cancer screening[J].Am Fam Physician,2001,64(5):729-730.
  • 8Herbest AL.The Bethesda system for reporting cervical/vaginal cytological diagnoses[J].Clin Obstet Gynecol,1992,35 (1):22-27.
  • 9Biscotti CV,Dawson AE,Dziura B,et al.Assisted primary screening using the automated ThinPrep Imaging System[J].Am J Clin Pathol,2005,123(2):281-287.
  • 10Pan Q,Belinson JL,Li L,et al.A thin-layer,liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma:a cross-sectional,comparative study[J].Acta Cytol,2003,47(1):45-50.

共引文献423

同被引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部